Fat Burning Femara Anti Estrogen Letrozole 98% CAS

ID:520885 View:170 Collection
Date Listed:  2017-09-10 Country:   China»Hubei»wuhan
Poster: liumu Company:  WuHan Yuancheng Co.Ltd.
Location:   No.496 ZhongShan Road WuHan,HuBei,China Website:  WuHan Yuancheng Co.Ltd.
Email: Mobile:  18908446183
Fax:   MSN:  

Detailed Product Description Fat Burning Femara Anti Estrogen Letrozole 98% CAS *-51-5 For Breast Cancer Quick Details: •Letrozole •Alias: Femara, Letrozole, TROZET •CAS Registry Number:*-51-5 •Purity: 98% •MF: C17H11N5 •MW: 285.3 •Character: White crystalline powder. •Other drugs in same class:Anastrozole,Letrozole,Tamoxifen citrate,Exemestane •Usage: Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from Letrozole include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system. Product Description: Product name Letrozole Other name Femara, Letrozole, TROZET CAS register number *-51-5 Molecular formula C17H11N5 Molecular weight 285.3 Molecular structure Assay 98% Appearance White crystalline powder Package 1kg/aluminium foil bag or as required Usage can be used as pharmaceutical material Minimum order quantity 10g Shipping By express courier Shipping leading time Within 12 hours after receiving the payment Payment options Western Union, MoneyGram, T/T Price Negotiated Application: Letrozole has been used for ovarian stimulation by fertility doctors since 2001 because it has fewer side-effects than clomiphene (Clomid) and less chance of multiple gestation. A Canadian study presented at the American Society of Reproductive Medicine 2005 Conference suggested that letrozole may increase the risk of birth defects.[citation needed] A more detailed ovulation induction follow-up study found that letrozole, compared with a control group of clomiphene, had significantly lower congenital malformations and chromosomal abnormalities


Please Note that this information was issued on!

Propyzamide 2017-11-18

Kinetin 2017-11-18


Forchlorfenuron 2017-11-18

Gibberellic acid 2017-11-18

Nitenpyram 2017-11-18

Lufenuron 2017-11-18


2,4-Dichlorophenoxyacetic acid2017-11-18

Hydroxyethyl Cellulose2017-11-18

Disodium 2-naphthol-3,6-disulfonate2017-11-18



Glycerol tristearate2017-11-18


Important Safety Warning: Avoid fraud by meeting all sellers in-person to pay for items. BestB2B.COM does not offer any transaction or payment services.